An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Summary

The purpose of this study is to assess the safety and effectiveness of BMS-986165 compared to placebo in participants with moderately to severely active Crohn's Disease.

Timeline

Start

2018-07-16

Primary completion

2022-12-12

Completion

2023-10-23

Drugs

Indications